The NCI SPORE program funds multi-project, translational cancer research centers that speed discoveries from bench to bedside. Projects must focus on a specific organ cancer or a biologically related group and achieve a human translational endpoint within the grant period to improve prevention, early detection, diagnosis, and treatment.
Eligibility Criteria:
-
Public/state-controlled and private institutions of higher education.
-
Nonprofits (with or without 501(c)(3) status).
-
For-profit organizations (including small businesses).
-
State, county, city/township, and special district governments; independent school districts.
-
Public housing authorities/Indian housing authorities.
-
Federally recognized Native American tribal governments and other eligible tribal organizations.
-
Faith-based/community-based organizations; regional organizations; eligible federal agencies.
-
Foreign institutions are not eligible; foreign components of U.S. organizations are allowed.
Funding Details:
-
Mechanism: P50 Research Center Grant (SPORE), clinical trial required.
-
Budget: Not specified in synopsis; must be appropriate to scope.
-
Expected number of awards: Not specified.
Deadline:
-
September 25, 2026 (5:00 PM local time of applicant organization).
Where to Go for Further Information:
-
General questions: [email protected]